ArticleFrontiers in endocrinology2022

Case Report: Tyrosine Kinase Inhibitors Induced Lymphadenopathy in Desmoid Tumor Patients.

Sotirios Papadopoulos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.